Takeda Pharmaceutical Company Limited Financials

Market Capitalization ¥6.931 Trillion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	66.23
Forward PE	31.61
Price to Sales TTM	¥1.51
Price to Book MRQ	¥1.01
Enterprise to Revenue	2.55
Enterprise to EBITDA	9.46

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-03-31
Profit Margin	2.36%
Operating Margin	11.68%
Return on Assets TTM	2.40%
Return on Equity TTM	1.52%

Income Statement

Revenue TTM	¥4,581,550,981,120
Revenue per Share TTM	¥2901.79
Quarterly Revenue Growth	0.20%
Gross Profit TTM	¥3,010,131,918,848
EBITDA	¥1,087,097,000,000
Net Income to Common TTM	¥107,928,002,560
Diluted EPS TTM	¥67.01
Quarterly Earnings Growth YoY	0.24%

Balance Sheet

Total Cash MRQ	¥385,112,997,888
Total Cash per Share MRQ	¥244.73
Total Debt MRQ	¥
Total Debt to Equity MRQ	73.37
Current Ratio MRQ	1.01
Book Value per Share MRQ	¥4407.01

Cash Flow

Operating Cash Flow TTM	¥1,057,181,990,912
Levered Free Cash Flow TTM	¥735,616,630,784

4502 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,573,649,646
Float Shares	1,572,673,983
Avg 10 Volume	3,589,430
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.03%
% Held by Institutions	47.19%

Stock Price Summary

Beta	0.26
Fifty Two Week Low	¥3852.00
Fifty Two Week High	¥4573.00
Fifty Two Week Change	4.78%
Day 50 MA	¥4274.74
Day 200 MA	¥4234.93

Dividends and Splits

Forward Annual Dividend Rate	¥196.00
Forward Annual Dividend Yield	4.41%
Trailing Annual Dividend Rate	¥196.00
Trailing Annual Dividend Yield	4.41%
Payout Ratio	291.54%
Dividend Date
Ex Dividend Date	2025-09-29
Last Split Factor
Last Split Date